Table 2 Other adverse events
From: A pilot study of toceranib/vinblastine therapy for canine transitional cell carcinoma
Other adverse events | Grade | Patients | Total number events |
|---|---|---|---|
Increased ALT | 1 | 1 | 1 |
4 | 1 | 1 | |
Increased AST | 1 | 1 | 1 |
Increased ALP | 2 | 1 | 1 |
Increased Creatinine | 1 | 1 | 1 |
2 | 1 | 1 | |
Anemia | 1 | 5 | 6 |
Thrombocytopenia | 1 | 1 | 1 |
Neutropenia | 1 | 6 | 7 |
2 | 2 | 2 | |
3 | 1 | 1 | |
4 | 1 | 1 | |
Limb Pain | 1 | 3 | 3 |